aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Percutaneous Systems (PercSys) is dedicated to developing and commercializing innovative medical devices that enhance the efficacy and reduce the trauma of endourologic kidney stone procedures. Their products are designed to improve outcomes of minimally invasive surgeries performed in operating rooms, with future devices aimed at expanding treatment to external and in-office settings.
PercSys has made significant strides in the medical field by introducing devices that simplify and improve kidney stone interventions. Their impact is evident in the enhanced therapeutic effectiveness and reduced patient trauma during procedures.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Medical Devices
Technology
Robotics
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Percutaneous Systems founded?
Percutaneous Systems was founded in 2002.
Where is Percutaneous Systems’s headquarters located?
Percutaneous Systems’s headquarters is located in Palo Alto, CA, US.
When was Percutaneous Systems’s last funding round?
Percutaneous Systems’s most recent funding round was for $4.8M (USD) in August 2011.
How many employees does Percutaneous Systems have?
Percutaneous Systems has 30 employees as of Feb 5, 2024.
How much has Percutaneous Systems raised to-date?
As of July 05, 2023, Percutaneous Systems has raised a total of $4.8M (USD) since Aug 15, 2011.
Add Comparison
Total Raised to Date
$4.8M
USD
Last Update Aug 15, 2011
Last Deal Details
$4.8M
USD
Aug 15, 2011
Debt Financing
Total Employees Over Time
30
As of Feb 2024
Percutaneous Systems Address
3260 Hillview Av
suite 100
Palo Alto,
California
94304
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts